tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ceribell Appoints Erica Rogers to Board of Directors

Story Highlights
Ceribell Appoints Erica Rogers to Board of Directors

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Ceribell, Inc. ( (CBLL) ) has provided an update.

On September 17, 2025, Ceribell, Inc. appointed Erica Rogers to its Board of Directors, highlighting her extensive experience in leading high-growth medical device companies. Rogers’ appointment is seen as a strategic move to support Ceribell’s mission to expand nationwide access to its point-of-care EEG system, which has already improved care for critically ill patients in over 550 hospitals. Her leadership is expected to be instrumental in establishing the Ceribell System as the standard of care in acute settings.

The most recent analyst rating on (CBLL) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on Ceribell, Inc. stock, see the CBLL Stock Forecast page.

Spark’s Take on CBLL Stock

According to Spark, TipRanks’ AI Analyst, CBLL is a Neutral.

Ceribell, Inc. shows strong revenue growth and improved financial position, but faces challenges with profitability, cash flow management, and legal issues. The stock is technically oversold, and valuation metrics suggest caution. The positive earnings call outlook is a significant strength, but operational inefficiencies and external financing reliance are key risks.

To see Spark’s full report on CBLL stock, click here.

More about Ceribell, Inc.

Ceribell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed for rapid diagnosis and continuous monitoring of neurological conditions. The Ceribell System is FDA-cleared for detecting suspected seizure activity and is used in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California.

Average Trading Volume: 325,761

Technical Sentiment Signal: Strong Sell

Current Market Cap: $449.1M

For detailed information about CBLL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1